Cargando…
In Vivo Fiber Optic Raman Spectroscopy of Muscle in Preclinical Models of Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy
[Image: see text] Neuromuscular diseases result in muscle weakness, disability, and, in many instances, death. Preclinical models form the bedrock of research into these disorders, and the development of in vivo and potentially translational biomarkers for the accurate identification of disease is c...
Autores principales: | Plesia, Maria, Stevens, Oliver A., Lloyd, Gavin R., Kendall, Catherine A., Coldicott, Ian, Kennerley, Aneurin J., Miller, Gaynor, Shaw, Pamela J., Mead, Richard J., Day, John C. C., Alix, James J. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154326/ https://www.ncbi.nlm.nih.gov/pubmed/33950665 http://dx.doi.org/10.1021/acschemneuro.0c00794 |
Ejemplares similares
-
Fiber optic Raman spectroscopy for the evaluation of disease state in Duchenne muscular dystrophy: An assessment using the mdx model and human muscle
por: Alix, James J. P., et al.
Publicado: (2022) -
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
por: Gruber, Dorota, et al.
Publicado: (2022) -
Comparison of Pulmonary Functions at Onset of Ventilatory Insufficiency in Patients With Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, and Myotonic Muscular Dystrophy
por: Cho, Han Eol, et al.
Publicado: (2016) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012) -
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)